COVID-19 Use Causes Tocilizumab Shortage

被引：4
|
作者：
Leslie, Mitch
机构：
来源：
CANCER DISCOVERY | 2021年 / 11卷 / 12期
关键词：
D O I：
10.1158/2159-8290.CD-NB2021-0386
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Based on mounting evidence that tocilizumab improves survival in critically ill patients with COVID-19, the FDA granted it an emergency use authorization for COVID-19 treatment in June. Two months later, the agency added tocilizumab to its list of drug shortages, where it remains despite a slowly increasing supply. ©2021 American Association for Cancer Research.
引用
收藏
页码：2950 / 2954
页数：5
相关论文
共 50 条
  • [11] Use of tocilizumab in kidney transplant recipients with COVID-19
    Perez-Saez, Maria J.
    Blasco, Miquel
    Redondo-Pachon, Dolores
    Ventura-Aguiar, Pedro
    Bada-Bosch, Teresa
    Perez-Flores, Isabel
    Melilli, Edoardo
    Sanchez-Camara, Luis A.
    Lopez-Oliva, Maria O.
    Canal, Cristina
    Shabaka, Amir
    Garra-Moncau, Nuria
    Martin-Moreno, Paloma L.
    Lopez, Veronica
    Hernandez-Gallego, Roman
    Siverio, Orlando
    Galeano, Cristina
    Espi-Reig, Jordi
    Cabezas, Carlos J.
    Rodrigo, Maria T.
    Llinas-Mallol, Laura
    Fernandez-Reyes, Maria J.
    Cruzado-Vega, Leonidas
    Perez-Tamajon, Lourdes
    Santana-Estupinan, Raquel
    Ruiz-Fuentes, Maria C.
    Tabernero, Guadalupe
    Zarraga, Sofia
    Ruiz, Juan C.
    Gutierrez-Dalmau, Alex
    Mazuecos, Auxiliadora
    Sanchez-Alvarez, Emilio
    Crespo, Marta
    Pascual, Julio
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (11) : 3182 - 3190
  • [12] Tocilizumab for the treatment of COVID-19
    Fernandez-Ruiz, Mario
    Lopez-Medrano, Francisco
    Aguado, Jose Maria
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 431 - 434
  • [13] Tocilizumab for the treatment of COVID-19
    Flisiak, Robert
    Flisiak-Jackiewicz, Marta
    Rzymski, Piotr
    Zarebska-Michaluk, Dorota
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (08) : 791 - 797
  • [14] Time for tocilizumab in COVID-19?
    Ethan Butler
    Marie Warrer Munch
    Balasubramanian Venkatesh
    Intensive Care Medicine, 2021, 47 : 692 - 694
  • [15] Time for tocilizumab in COVID-19?
    Butler, Ethan
    Munch, Marie Warrer
    Venkatesh, Balasubramanian
    INTENSIVE CARE MEDICINE, 2021, 47 (06) : 692 - 694
  • [16] Tocilizumab in severe COVID-19
    Liberato, Nicola Lucia
    De Monte, Andrea
    Caravella, Giuseppe
    ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (06) : 1457 - 1458
  • [17] Tocilizumab therapy and COVID-19
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    JOURNAL OF OSTEOPATHIC MEDICINE, 2021, 121 (11): : 865 - 865
  • [18] Tocilizumab in Covid-19 Reply
    Stone, John H.
    Horick, Nora K.
    Healy, Brian C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (01): : 87 - 87
  • [19] The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
    Manuel Rubio-Rivas
    José M. Mora-Luján
    Abelardo Montero
    Josefa Andrea Aguilar García
    Manuel Méndez Bailón
    Ana Fernández Cruz
    Isabel Oriol
    Francisco-Javier Teigell-Muñoz
    Beatriz Dendariena Borque
    Andrés De la Peña Fernández
    Raquel Fernández González
    Ricardo Gil Sánchez
    Javier Fernández Fernández
    Marta Catalán
    Begoña Cortés-Rodríguez
    Carmen Mella Pérez
    Lorena Montero Rivas
    Rebeca Suárez Fuentetaja
    Jara Eloísa Ternero Vega
    Javier Ena
    Anabel Martin-Urda Díez-Canseco
    Cristina Pérez García
    José F. Varona
    José Manuel Casas-Rojo
    Jesús Millán Núñez-Cortés
    Journal of General Internal Medicine, 2022, 37 : 168 - 175
  • [20] Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma
    Potere, Nicola
    Di Nisio, Marcello
    Cibelli, Donatella
    Scurti, Rosa
    Frattari, Antonella
    Porreca, Ettore
    Abbate, Antonio
    Parruti, Giustino
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (11)
12345